Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

MPN - 469

Clinical Profile, Molecular Landscape, and Outcomes of Myelofibrosis in Lebanon: Real-World Data

Hiba Smaily

Poster Presenter: Hiba Smaily

Thumbnail for Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, is Well Tolerated and Achieves Rapid and Sustained Hematologic and Molecular Responses in Patients With Essential Thrombocythemia (ET)

MPN - 481

Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, is Well Tolerated and Achieves Rapid and Sustained Hematologic and Molecular Responses in Patients With Essential Thrombocythemia (ET)

Haris Ali

Poster Presenter: Haris Ali

Previous 1...131 132 133 134 135 136 137...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Clinical Phenotype and Survival Follow-Up in NRAS/KRAS-Mutated Juvenile Myelomonocytic Leukemia: A Single-Center Cohort

MPN - 487

Clinical Phenotype and Survival Follow-Up in NRAS/KRAS-Mutated Juvenile Myelomonocytic Leukemia: A Single-Center Cohort

Bang Zhang

Poster Presenter: Bang Zhang

Thumbnail for Genetic Analysis of Triple-Negative Myeloproliferative Neoplasms Using Whole-Exome Sequencing

MPN - 491

Genetic Analysis of Triple-Negative Myeloproliferative Neoplasms Using Whole-Exome Sequencing

Munira Borhany

Poster Presenter: Munira Borhany

Thumbnail for Concurrent Thrombosis and Hemorrhage in Myeloproliferative Neoplasms: Impact on In-Hospital Outcomes, an NIS-Based Study

MPN - 508

Concurrent Thrombosis and Hemorrhage in Myeloproliferative Neoplasms: Impact on In-Hospital Outcomes, an NIS-Based Study

Ameerdad Khan

Poster Presenter: Ameerdad Khan

Thumbnail for Timing of TP53 Mutation Acquisition as a Determinant of Outcomes in Patients with Myeloproliferative Neoplasms and Myeloproliferative Neoplasms/ Myelodysplastic Syndromes.

MPN - 528

Timing of TP53 Mutation Acquisition as a Determinant of Outcomes in Patients with Myeloproliferative Neoplasms and Myeloproliferative Neoplasms/ Myelodysplastic Syndromes.

Sharan Jhaveri

Poster Presenter: Sharan Jhaveri

$Thumbnail for The selective PI3Kd inhibitor roginolisib synergizes with JAK inhibitors in progenitor cells from naοve and JAK inhibitor-refractory/resistant patients with myelofibrosis$

MPN - 545

The selective PI3Kd inhibitor roginolisib synergizes with JAK inhibitors in progenitor cells from naοve and JAK inhibitor-refractory/resistant patients with myelofibrosis

Giusy Di Conza

Poster Presenter: Giusy Di Conza

Thumbnail for Preclinical Evaluation of INCA035784, a Novel T-Cell-Redirecting Antibody for the Treatment of MutCALR-Driven Myeloproliferative Neoplasms (MPNs)

MPN - 553

Preclinical Evaluation of INCA035784, a Novel T-Cell-Redirecting Antibody for the Treatment of MutCALR-Driven Myeloproliferative Neoplasms (MPNs)

Liang-Chuan Wang

Poster Presenter: Liang-Chuan Wang

Thumbnail for Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, Is Well Tolerated and Achieves Robust Spleen, Anemia, and Molecular Responses in Patients With Myelofibrosis

MPN - 554

Mutant Calreticulin-Specific Monoclonal Antibody, INCA033989, Is Well Tolerated and Achieves Robust Spleen, Anemia, and Molecular Responses in Patients With Myelofibrosis

Tania Jain

Poster Presenter: Tania Jain

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors